{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:27:48Z","timestamp":1740126468292,"version":"3.37.3"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>As the majority of T-cell lymphomas lack CD20 expression, cases of mycosis fungoides (MF) exhibiting aberrant CD20 expression are exceedingly uncommon.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To comprehensively evaluate the clinical, histopathological and prognostic features of seven patients diagnosed with CD20+ MF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective study involved seven cases of MF with aberrant CD20 expression. The study provides details of demographics, clinical features, histopathology and treatment outcomes. Key timepoints include initial diagnosis of MF, detection of CD20 expression and follow-up, with a mean follow-up of 46\u2005months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Aberrant CD20+ MF was diagnosed at an average age of 58.6\u2005years, approximately 5.6\u2005years after the first MF diagnosis. Following CD20 detection, patients presented with advanced disease stages, requiring treatments such as chemotherapy, brentuximab vedotin and allogeneic haematopoietic stem cell transplantation. Four patients died from lymphoma, with an average survival time of 52\u2005months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Aberrant CD20 expression in MF is rare but indicates a progressive course associated with poor prognosis. This often requires systemic chemotherapy and, in certain instances, allogeneic haematopoietic stem cell transplantation. This study provides important insights into the clinical attributes, disease progression and treatment options for patients with MF with aberrant CD20 expression. Further research is necessary to validate the effectiveness of emerging therapies and enhance our understanding of the underlying mechanisms and prognostic determinants specific to this unique MF subgroup.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ced\/llae297","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T17:24:59Z","timestamp":1722360299000},"page":"1651-1658","source":"Crossref","is-referenced-by-count":0,"title":["A comprehensive study on aberrant CD20+ mycosis fungoides: clinical and prognostic insights"],"prefix":"10.1093","volume":"49","author":[{"given":"Hatice","family":"\u015eanl\u0131","sequence":"first","affiliation":[{"name":"Department of Dermatology, Ankara University Faculty of Medicine , Ankara ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130ncilay","family":"Y\u0131ld\u0131zhan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ankara University Faculty of Medicine , Ankara ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2732-9132","authenticated-orcid":false,"given":"Merve","family":"Al\u0131zada","sequence":"additional","affiliation":[{"name":"Mamak State Hospital, Department of Dermatology , Ankara ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Taha","family":"Aydemir","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ankara University Faculty of Medicine , Ankara ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aylin Ok\u00e7u","family":"Heper","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ankara University Faculty of Medicine , Ankara ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u00e7a","family":"K\u0131rm\u0131z\u0131","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ankara University Faculty of Medicine , Ankara ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4896-1666","authenticated-orcid":false,"given":"Bengu Nisa","family":"Akay","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ankara University Faculty of Medicine , Ankara ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"key":"2024112216160843800_llae297-B1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.3880265","article-title":"Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall","volume":"14","author":"Yao","year":"2001","journal-title":"Mod Pathol"},{"key":"2024112216160843800_llae297-B2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/jcp.2003.011734","article-title":"CD20 positive T cell lymphoma: is it a real entity?","volume":"57","author":"Sun","year":"2004","journal-title":"J Clin Pathol"},{"key":"2024112216160843800_llae297-B3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s002770100297","article-title":"CD20+ T cell leukemia\/lymphoma: case report and review of the literature","volume":"80","author":"Yokose","year":"2001","journal-title":"Ann Hematol"},{"key":"2024112216160843800_llae297-B4","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/DAD.0b013e31827b9450","article-title":"CD20+ mycosis fungoides: a report of three cases and review of the literature","volume":"35","author":"Hagen","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"2024112216160843800_llae297-B5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/cup.12299","article-title":"Mycosis fungoides with CD20 expression: report of two cases and review of the literature","volume":"41","author":"Harms","year":"2014","journal-title":"J Cutan Pathol"},{"key":"2024112216160843800_llae297-B6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1600-0560.2011.01709.x","article-title":"Primary cutaneous CD20+ T-cell lymphoma","volume":"38","author":"Martin","year":"2011","journal-title":"J Cutan Pathol"},{"key":"2024112216160843800_llae297-B7","first-page":"1021","article-title":"[CD20+ T cell lymphoma: clinicopathological features of five cases]","volume":"49","author":"Shao","year":"2020","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"2024112216160843800_llae297-B8","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1097\/PAS.0b013e31817d7452","article-title":"CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature","volume":"32","author":"Rahemtullah","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"2024112216160843800_llae297-B9","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1600-0560.2007.00817.x","article-title":"CD20 positive mycosis fungoides: a case report","volume":"35","author":"Sen","year":"2008","journal-title":"J Cutan Pathol"},{"key":"2024112216160843800_llae297-B10","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1097\/PAS.0000000000000091","article-title":"CD20 antigen may be expressed by reactive or lymphomatous cells of transformed mycosis fungoides: diagnostic and prognostic impact","volume":"37","author":"Julli\u00e9","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"2024112216160843800_llae297-B11","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2011-08-376319","article-title":"Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases","volume":"119","author":"Benner","year":"2012","journal-title":"Blood"},{"key":"2024112216160843800_llae297-B12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1309\/AJCPOBDP2OQAJ5BR","article-title":"Mycosis fungoides: report of the 2011 Society for Hematopathology\/European Association for Haematopathology workshop","volume":"139","author":"Song","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"2024112216160843800_llae297-B13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/cup.14643","article-title":"Null T-cell phenotype mycosis fungoides with aberrant CD20 and CD56 expression: a diagnostic dilemma","volume":"51","author":"Aran","year":"2024","journal-title":"J Cutan Pathol"},{"key":"2024112216160843800_llae297-B14","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/DAD.0000000000002056","article-title":"Gamma-delta and CD20 mycosis fungoides: two cases uncovered by broad-spectrum immunostaining","volume":"43","author":"Patel","year":"2021","journal-title":"Am J Dermatopathol"},{"key":"2024112216160843800_llae297-B15","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jdcr.2020.01.015","article-title":"CD20+ cutaneous T-cell lymphoma with phenotypic shift after treatment with rituximab: case report and review of the literature","volume":"6","author":"Tschetter","year":"2020","journal-title":"JAAD Case Rep"},{"key":"2024112216160843800_llae297-B16","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","article-title":"Defining early mycosis fungoides","volume":"53","author":"Pimpinelli","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"2024112216160843800_llae297-B17","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"2024112216160843800_llae297-B18","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and S\u00e9zary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"2024112216160843800_llae297-B19","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1083\/jcb.121.5.1121","article-title":"Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytes","volume":"121","author":"Bubien","year":"1993","journal-title":"J Cell Biol"},{"key":"2024112216160843800_llae297-B20","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1056\/NEJMct1114348","article-title":"Anti-CD20 antibody therapy for B-cell lymphomas","volume":"366","author":"Maloney","year":"2012","journal-title":"N Engl J Med"},{"key":"2024112216160843800_llae297-B21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cyto.990140212","article-title":"CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes","volume":"14","author":"Hultin","year":"1993","journal-title":"Cytometry"},{"key":"2024112216160843800_llae297-B22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/ajcp\/106.1.78","article-title":"CD20 (pan-B cell antigen) expression on bone marrow-derived T cells","volume":"106","author":"Algino","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"2024112216160843800_llae297-B23","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.pathol.2022.02.008","article-title":"Prevalence of T-cell antigen losses in mycosis fungoides and CD30+ cutaneous T-cell lymphoproliferations in a series of 153 patients","volume":"54","author":"Wechsler","year":"2022","journal-title":"Pathology"},{"key":"2024112216160843800_llae297-B24","first-page":"323","article-title":"Circulating CD20dim T-lymphocytes increase with age: evidence for a memory cytotoxic phenotype","volume":"17","author":"Storie","year":"1995","journal-title":"Clin Lab Haematol"},{"key":"2024112216160843800_llae297-B25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/ajcp\/102.4.483","article-title":"CD20+ T-cell lymphoma. Neoplastic transformation of a normal T-cell subset","volume":"102","author":"Quintanilla-Martinez","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"2024112216160843800_llae297-B26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1348-0421.1996.tb01096.x","article-title":"Transient expression of CD20 antigen (pan B cell marker) in activated lymph node T cells","volume":"40","author":"Murayama","year":"1996","journal-title":"Microbiol Immunol"},{"key":"2024112216160843800_llae297-B27","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1046\/j.1365-2141.1998.00884.x","article-title":"CD20+ T-cell chronic lymphocytic leukaemia","volume":"102","author":"Takami","year":"1998","journal-title":"Br J Haematol"},{"key":"2024112216160843800_llae297-B28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00062752-200307000-00003","article-title":"Expression and a role of CD30 in regulation of T-cell activity","volume":"10","author":"Tarkowski","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"2024112216160843800_llae297-B29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/his.14660","article-title":"Intraindividual variability of CD30 expression in mycosis fungoides \u2013 implications for diagnostic evaluation and therapy","volume":"81","author":"Mitteldorf","year":"2022","journal-title":"Histopathology"},{"key":"2024112216160843800_llae297-B30","first-page":"2212","article-title":"Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneous Lymphomas","volume":"95","author":"Vergier","year":"2000","journal-title":"Blood"},{"key":"2024112216160843800_llae297-B31","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.leukres.2008.09.034","article-title":"Rituximab for the treatment of CD20+ peripheral T-cell lymphoma, unspecified","volume":"33","author":"Hirata","year":"2009","journal-title":"Leuk Res"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llae297\/59616870\/llae297.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/12\/1651\/60790416\/llae297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/12\/1651\/60790416\/llae297.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T16:16:30Z","timestamp":1732292190000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/49\/12\/1651\/7724235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,7,30]]},"published-print":{"date-parts":[[2024,11,22]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llae297","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"type":"print","value":"0307-6938"},{"type":"electronic","value":"1365-2230"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,7,30]]}}}